GLP-1 Injection Site Reactions: Causes and Management

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Injection site reactions occur in 5-10% of adults using GLP-1 medications (semaglutide, tirzepatide, dulaglutide, liraglutide).
  • Common reactions include redness, itching, mild swelling, bruising, and small lumps at the injection site.
  • Most reactions resolve within 1-3 days and don't require treatment.
  • Site rotation, proper injection technique, and bringing the medication to room temperature reduce reactions.
  • Severe reactions (large hives, spreading rash, breathing difficulty) require immediate medical attention.

Injection site reactions occur in 5 to 10% of adults using GLP-1 medications (semaglutide, tirzepatide, dulaglutide, liraglutide). Common reactions include redness, itching, mild swelling, bruising, and small lumps at the injection site. Most reactions are mild and resolve within 1-3 days without treatment. The reactions reflect local irritation from the medication, the needle, or the injection technique rather than true drug allergy. Severe reactions (large hives, spreading rash, facial swelling, breathing difficulty) are rare but require immediate medical attention. Prevention strategies include site rotation between abdomen, thigh, and upper arm; bringing the medication to room temperature before injection; proper injection technique with 90-degree angle into subcutaneous fat; and avoiding scarred or irritated areas. Most adults find that consistent technique and rotation prevent recurring reactions.

Common Reaction Types

  • Redness (erythema): pink to red area 1-3 inches around injection site.
  • Itching: at and around site; may extend slightly beyond.
  • Mild swelling: small raised bump for hours to days.
  • Bruising: purple-red discoloration if needle hit small vessel.
  • Subcutaneous nodule: small firm lump under skin lasting days to weeks.
  • Hives (urticaria): raised itchy welts — possible local allergic reaction.
  • Pain or stinging: at injection or shortly after.

Site Rotation Schedule

Week Region Specific Site
1 Abdomen Upper right (avoid 2-inch radius around navel)
2 Thigh Right anterior outer thigh
3 Upper arm Right posterior upper arm (if reachable)
4 Abdomen Upper left
5 Thigh Left anterior outer thigh
6 Upper arm Left posterior upper arm
7 Abdomen Lower right (still avoid navel)
8 Continue cycle Returning to thigh

Proper Injection Technique

  • Bring medication to room temperature (15-30 minutes out of refrigerator).
  • Wash hands.
  • Inspect medication — should be clear, colorless to slightly yellow.
  • Clean injection site with alcohol pad; let dry completely.
  • Pinch a 2-inch fold of skin (avoid muscle).
  • Insert needle at 90-degree angle (perpendicular to skin).
  • Press injection button and hold for 5-10 seconds per pen instructions.
  • Withdraw needle at same angle.
  • Apply gentle pressure if bleeding; don’t rub.
  • Dispose of pen needle in sharps container.

When to Seek Medical Care

  • Large hives or widespread rash beyond injection site.
  • Swelling of face, lips, tongue, or throat (anaphylaxis warning).
  • Difficulty breathing or wheezing.
  • Dizziness or fainting.
  • Signs of infection — increasing redness, warmth, pus, fever days after injection.
  • Severe pain that persists.
  • Hard nodule lasting weeks without resolving.
  • Reactions worsening rather than improving over days.

Treatments for Reactions

  • Mild itching: topical hydrocortisone 1% cream (OTC); oral antihistamine (cetirizine, loratadine).
  • Mild swelling/redness: cool compress 10-15 minutes; usually self-resolves.
  • Bruising: arnica cream or cool compress; resolves over 1-2 weeks.
  • Persistent nodule: warm compress; typically resolves over weeks.
  • Severe/widespread reactions: oral antihistamine; medical evaluation; possible discontinuation.
  • Suspected infection: medical evaluation; possible antibiotics.

The Bottom Line

Injection site reactions occur in 5-10% of adults using GLP-1 medications (semaglutide, tirzepatide, dulaglutide, liraglutide). Common reactions include redness, itching, mild swelling, bruising, and small lumps at the injection site. Most reactions are mild and resolve within 1-3 days without treatment. Prevention strategies include site rotation between abdomen, thigh, and upper arm (alternating weekly); bringing the medication to room temperature before injection (15-30 minutes out of refrigerator); proper technique with 90-degree angle injection into subcutaneous fat; avoiding scarred or irritated areas; and not rubbing the site after injection. For symptomatic relief, topical hydrocortisone 1% cream or oral antihistamine helps mild itching; cool compress reduces swelling. Most adults find consistent technique and rotation prevent recurring reactions. Severe reactions are rare but require immediate medical attention — these include large hives or widespread rash, swelling of face/lips/tongue/throat, difficulty breathing, fainting, signs of infection (increasing redness, warmth, pus, fever days after injection), or persistent hard nodules. See our broader GLP-1 medications guide for context.

Frequently Asked Questions

What do GLP-1 injection site reactions look like?

Common appearances include (1) redness — pink to red area 1-3 inches around injection site; (2) itching at and around site; (3) mild swelling or raised bump; (4) bruising — purple-red discoloration if needle hit a small vessel; (5) small firm lump under the skin (subcutaneous nodule). Most reactions are mild and resolve within 1-3 days. About 5-10% of adults using GLP-1 medications experience injection site reactions.

How can I reduce injection site reactions?

Several techniques help. (1) Site rotation — alternate between abdomen, thigh, and upper arm; within a region, rotate to a different spot each week. (2) Bring medication to room temperature — let pen sit out 15-30 minutes before injection. (3) Clean skin with alcohol, let dry completely before injection. (4) Inject at 90-degree angle into subcutaneous fat. (5) Don't rub the area after injection — apply gentle pressure if needed. (6) Inject slowly. (7) Avoid scarred, bruised, or irritated areas. (8) Avoid the same site for at least 1-2 weeks.

When should I worry about an injection reaction?

Most reactions are minor and resolve quickly. Seek medical attention for (1) large hives or widespread rash; (2) swelling of face, lips, tongue, or throat; (3) difficulty breathing or wheezing; (4) dizziness or fainting; (5) signs of infection at injection site — increasing redness, warmth, pus, fever beginning days after injection; (6) severe pain that persists; (7) hard nodule that doesn't resolve over weeks. Anaphylaxis to GLP-1 medications is rare but possible — call 911 if breathing or facial swelling occurs.

Should I switch sites or stop the medication?

Switching sites is usually sufficient for mild reactions. If reactions occur consistently at one site type (e.g., always abdomen), try thigh or upper arm. Stopping the medication is rarely needed for injection site reactions alone — they're typically mild and tolerable. Discuss with your prescriber if (1) reactions are severe; (2) reactions are widespread (suggesting allergic reaction rather than local irritation); (3) reactions persist beyond a few days regularly. Pre-medication with antihistamine before injection occasionally helps adults with significant itching.

Sources

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine.
  3. American Diabetes Association. Standards of Care in Diabetes—2024.